Venture Capital Access Online | The eMarketplace for the Venture Capital Industry


Bookmark and Share   


Contact Us






Venture Capital Database 2015 Now Available!

Nanomix Closes Private Financing

EMERYVILLE, Calif., January 30, 2014-- Nanomix Inc., (Nanomix), a leading nanotechnology company focused on development of next generation Point of Care diagnostic tests to enable earlier and more accurate testing in hospital and pre-hospital settings, today announced that is has closed private financing for approximately $12 million. The financing, received from a strategic corporate partner and existing investors, will fund the completion of development, registration clinical trials, and commercial launch of the Company's mobile diagnostic platform and initial assays.

About Nanomix Inc.

Nanomix's leadership in carbon nanotubes and nanoscale electronic sensors has enabled the development of the next generation of Point of Care testing systems where superior performance and rapid results can both be achieved in virtually any setting. The Nanomix mobile diagnostic platform, performs multiple in-vitro diagnostic assays simultaneously from a single whole-blood sample. The compact size of the electronic instrument and credit card sized disposable test cartridge can be configured to run a wide variety of tests using various assay techniques.

Nanomix Laboratory Performance at the Point of Care, visit:

Joy Bissell
Nanomix Inc.
5980 Horton St, Suite 600
Emeryville, CA 94608
Phone: 1-510-428-5300

News Index

Venture Capital Database 



Latest VC News
VC News Archive
News Search
RSS News Feed

List Your Firm


Venture Capital Database

VCPro Database
Download Trial
Buy Now

VC Tools

VC Pitch
Private Placement Memorandum

Business Plan Tools

Free Business Plan Template
Business Plan Tools



Copyright 1998-2015 Access InterComm  All rights reserved. 
Site Map | Privacy Statement | Legal Notice & Disclaimer